CEREVEL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) Buyout and Encourages Investors to Contact the Firm
Kaskela Law LLC announces that it is investigating Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) (“Cerevel”) on behalf of the company’s sharehold Kaskela Law LLC is investigating the fairness of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) (Cerevel), which is set to be acquired by AbbVie Inc. in 2023 at a price of $45.00 per share. Following the transaction, current stockholders will be cashed out of their investment position and the company’s shares will no longer be publicly traded. The investigation will determine if Cerevel’�s officers and directors breached their fiduciary duties or violated the securities laws in agreeing to sell the company to Abbvie. Kaskela Legal LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis.
gepubliceerd : 10 maanden geleden door in Finance
PHILADELPHIA--( )--Kaskela Law LLC announces that it is investigating Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) (“Cerevel”) on behalf of the company’s shareholders.
On December 6, 2023, Cerevel announced that it had agreed to be acquired by AbbVie Inc. at a price of in cash. Following the closing of the proposed transaction, Cerevel’s current stockholders will be cashed out of their investment position and the company’s shares will no longer be publicly traded.
The investigation seeks to determine whether Cerevel’s officers and/or directors breached their fiduciary duties or violated the securities laws in agreeing to sell the company to AbbVie at a $45.00 per share valuation.
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com .
This notice may constitute attorney advertising in certain jurisdictions.
KASKELA LAW LLC D. Seamus Kaskela, Esq. ( [email protected] ) Adrienne Bell, Esq. ( [email protected] ) 18 Campus Blvd., Suite 100 Newtown Square, PA 19073 (888) 715 – 1740 (484) 229 – 0750 www.kaskelalaw.com
Onderwerpen: Markets